These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18500253)

  • 1. Hematopoietic cell transplantation provides an immune-tolerant platform for myoblast transplantation in dystrophic dogs.
    Parker MH; Kuhr C; Tapscott SJ; Storb R
    Mol Ther; 2008 Jul; 16(7):1340-6. PubMed ID: 18500253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell transplantation does not restore dystrophin expression in Duchenne muscular dystrophy dogs.
    Dell'Agnola C; Wang Z; Storb R; Tapscott SJ; Kuhr CS; Hauschka SD; Lee RS; Sale GE; Zellmer E; Gisburne S; Bogan J; Kornegay JN; Cooper BJ; Gooley TA; Little MT
    Blood; 2004 Dec; 104(13):4311-8. PubMed ID: 15328150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
    Lala-Tabbert N; Fu D; Wiper-Bergeron N
    Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy.
    Siemionow M; Cwykiel J; Heydemann A; Garcia-Martinez J; Siemionow K; Szilagyi E
    Stem Cell Rev Rep; 2018 Apr; 14(2):189-199. PubMed ID: 29305755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of Functional Full-Length Dystrophin After Intramuscular Transplantation of Foamy Virus-Transduced Myoblasts.
    Meng J; Sweeney NP; Doreste B; Muntoni F; McClure M; Morgan J
    Hum Gene Ther; 2020 Feb; 31(3-4):241-252. PubMed ID: 31801386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
    Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy.
    Siemionow M; Cwykiel J; Heydemann A; Garcia J; Marchese E; Siemionow K; Szilagyi E
    Stem Cell Rev Rep; 2018 Jun; 14(3):370-384. PubMed ID: 29546607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Co-transplantation of myoblasts and schwann cells in the therapy of Duchenne muscular dystrophy].
    Luo L; Zhou HY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):101-5. PubMed ID: 21355312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transplantation of normal or genetically modified myoblasts for the treatment of hereditary or acquired diseases].
    Tremblay JP; Vilquin JT
    J Soc Biol; 2001; 195(1):29-37. PubMed ID: 11530497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
    Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
    Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcolipin overexpression impairs myogenic differentiation in Duchenne muscular dystrophy.
    Niranjan N; Mareedu S; Tian Y; Kodippili K; Fefelova N; Voit A; Xie LH; Duan D; Babu GJ
    Am J Physiol Cell Physiol; 2019 Oct; 317(4):C813-C824. PubMed ID: 31365291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle engraftment of myogenic progenitor cells following intraarterial transplantation.
    Bachrach E; Perez AL; Choi YH; Illigens BM; Jun SJ; del Nido P; McGowan FX; Li S; Flint A; Chamberlain J; Kunkel LM
    Muscle Nerve; 2006 Jul; 34(1):44-52. PubMed ID: 16634061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro.
    Vieira NM; Brandalise V; Zucconi E; Jazedje T; Secco M; Nunes VA; Strauss BE; Vainzof M; Zatz M
    Biol Cell; 2008 Apr; 100(4):231-41. PubMed ID: 17997718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Muscle Function Following hiPSC-Derived Myoblast Transplantation in Dystrophic Mice.
    Fabre P; Molina T; Orfi Z; Dumont NA
    Curr Protoc; 2022 Jan; 2(1):e356. PubMed ID: 35085428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inefficient dystrophin expression after cord blood transplantation in Duchenne muscular dystrophy.
    Kang PB; Lidov HG; White AJ; Mitchell M; Balasubramanian A; Estrella E; Bennett RR; Darras BT; Shapiro FD; Bambach BJ; Kurtzberg J; Gussoni E; Kunkel LM
    Muscle Nerve; 2010 Jun; 41(6):746-50. PubMed ID: 20513101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A
    Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell-based therapies for Duchenne muscular dystrophy.
    Sun C; Serra C; Lee G; Wagner KR
    Exp Neurol; 2020 Jan; 323():113086. PubMed ID: 31639376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin.
    Vieira NM; Valadares M; Zucconi E; Secco M; Bueno CR; Brandalise V; Assoni A; Gomes J; Landini V; Andrade T; Caetano HV; Vainzof M; Zatz M
    Cell Transplant; 2012; 21(7):1407-17. PubMed ID: 23168016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy.
    Qu Z; Huard J
    Gene Ther; 2000 Mar; 7(5):428-37. PubMed ID: 10694825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.